Results 41 to 50 of about 11,360 (219)
Objective/Hypothesis Middle ear cholesteatoma is characterized by abnormal growth of the keratinizing squamous epithelium of the temporal bone. d‐β‐aspartic acid is the major isomer of d‐aspartic acid found in elderly tissue.
Shiori Kitaya +12 more
doaj +1 more source
Acquired ear canal stenosis can be caused by trauma, inflammation, postoperative scar formation, or tumors. There is a risk of cholesteatoma formation because of keratinized deposits in the closed space, with a reduction in quality of life because of ...
Ryota Tomioka +4 more
doaj +1 more source
BACKGROUND: In this study, we aimed to compare the success rates of computed tomography image-based artificial intelligence models and magnetic resonance imaging in the diagnosis of preoperative cholesteatoma.
Hanefi Yildirim +29 more
core +1 more source
Chronic Draining Ear and Cholesteatoma Recidivism: A Retrospection from Clinical, Imaging, and Surgical Perspectives [PDF]
Objective:To evaluate the reasons for persistent draining ear and cholesteatoma recidivism following canal wall down (CWD) tympanomastoidectomy by studying the sensitivity of high-resolution computed tomography (HRCT) scanning in different potential ...
Saumik Das +3 more
core +1 more source
Modified classification of infralabyrinthie cholesteatoma and scale of cholesteatoma extention [PDF]
Introduction. Petrous temporal bone (PTB) cholesteatoma is an epidermal cyst, which is the result of uncontrolled growth of keratinizing squamous epithelium in the petrous part of the temporal bone.
O. S. Panina +2 more
core +1 more source
Cholesteatoma of the Ear [PDF]
n ...
openaire +1 more source
Pathology and treatment of cholesteatoma
Cholesteatoma is a cystic non-neoplastic lesion of a temporal bone that shows hyperproliferation of keratinocytes and abnormally heavy production of keratin in the tympanic cavity with the influence of chronic inflammation.
Cho, Young Jae
core
Cholesteatoma is characterized by both the overgrowth of hyperkeratinized squamous epithelium and bone erosion. However, the exact mechanism underlying the hyperproliferative ability of cholesteatoma remains unknown. In this study, we investigated PPAR β/
Chen Zhang +3 more
doaj +1 more source
Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium
The tumor suppressor CYLD is a deubiquitinating enzyme that inhibits activation of the NF-κB, which has key roles in inflammation and apoptosis. We hypothesized that CYLD may regulate the NF-κB signaling pathway in cholesteatoma.
Jae Yong Byun +4 more
doaj +1 more source
Notch Signaling in Acquired Middle Ear Cholesteatoma [PDF]
Hypothesis: We hypothesized that an anomalous change of Notch signaling might be involved in the pathophysiology of cholesteatoma. Background: The Notch signaling pathway regulates integrated growth and differentiation control of keratinocytes.
Fukuda, Atsushi +13 more
core +1 more source

